Books and/or Chapters

  1. Wolfe, P.S.; Sell, S.A. and G.L. Bowlin. “Natural and Synthetic Scaffolds.” In The Tissue Engineering Book: State of the Art, Visions and Limitations. Springer-Verlag GmbH, Heidelberg, Germany, In Press.

  2. Garg, K.; Sell, S.A. and G.L. Bowlin. “Electrospinning and Its Influence on the Structure of Polymeric Nanofibers.” In Handbook of Textile Fibre Structure. Woodhead Publishing in Textiles: Number 88, Eichhorn, S.; Hearle, J.W.S.; Jaffe, M. and T. Kikutani, Eds. Woodhead Publishing Limited, Cambridge, UK, 958-981, 2009.

  3. Boland, E.D., Pawlowski, K.J., Barnes, C.P.; Simpson, D.G., Wnek, G.E. and G.L. Bowlin. "Electrospinning of Bioresorbable Polymers for Tissue Engineering Scaffolds.” In Polymeric Nanofibers. Reneker, D.H. and YH. Fong, Eds., American Chemical Society, 188-204, 2006.

  4. Keen, C.; Bowlin, G.L. and D.G. Simpson. “Tissue Engineering Skeletal Muscle.” In Encyclopedia of Biomaterials and Biomedical Engineering. G.E. Wnek and G.L. Bowlin, Eds., Marcel Dekker, N.Y., Volume 2: 1639-51, 2004.

  5. Telemeco, T.; Ellis, R.; Bowman, J.; Bowlin, G.L. and D.G. Simpson. “Matrix Metalloproteinases.” In Encyclopedia of Biomaterials and Biomedical Engineering. G.E. Wnek and G.L. Bowlin, Eds., Marcel Dekker, N.Y., Volume 2: 963-74, 2004.

  6. Editor: "Encyclopedia of Biomaterials and Biomedical Engineering" (G.E. Wnek, Co-editor) Marcel Dekker, Inc., New York, N.Y. Expected Publication: Early 2004.

  7. Boland, E.D.; Espy, P. and G.L. Bowlin. "Tissue Engineering Scaffolds." In Encyclopedia of Biomaterials and Biomedical Engineering. G.E. Wnek and G.L. Bowlin, Eds., Marcel Dekker, N.Y., 2004.

  8. Boland, E.D.; Wnek, G.E. and G.L. Bowlin. "Poly(Gylcolic Acid)" In Encyclopedia of Biomaterials and Biomedical Engineering. G.E. Wnek and G.L. Bowlin, Eds., Marcel Dekker, N.Y., 2004.

  9. Bowlin, G.L., Pawlowski, K.J., Stitzel, J.D., Boland, E.D., Simpson, D.G., Fenn, J.B. and G.E. Wnek. "Electrospinning of Polymer Scaffolds for Tissue Engineering." In Tissue Engineering and Biodegradable Equivalents: Scientific and Clinical Applications. K. Lewandrowsky, D. J. Trantolo, J. D. Gresser, M. J. Yaszemski, D. E. Altobelli and D. L. Wise, Eds, Marcel Dekker, N.Y., Chapter 9: 65-178: 2002.

  10. Bowlin, G.L. Schmidt, S.P., Rittgers, S.E., and K.J. Pawlowski. "Endothelialization of Vascular Prostheses." In Biomaterials Engineering & Devices: Human Applications. D. Wise, et al., Eds. The Humana Press, Inc., Chapter 6: 85-118: 2000.

  11. Schmidt, S.P. and G.L. Bowlin. "Endothelial Cell Seeding: A Review." In Tissue Engineering of Prosthetic Vascular Grafts. P.P. Zilla and H.P. Greisler, Eds. Academic Press, Chapter 3: 61-68; 1997.

Publications

  1. Smith, M.J.; White Jr., K.L. and G.L. Bowlin. “Electrospun Polydioxanone – Monocyte Chemotactic Protein-1 Hybrid Scaffolds as Potential Cellular Homing Devices for Use in Vascular Tissue Engineering.” Journal of Biomedical Materials Research-Part A, In Review. (Impact Factor: 2.612)

  2. McClure, M.J.; Sell, S.A.; Simpson, D.G.; Walpoth, B.H. and G.L. Bowlin. “A Three Layered Electrospun Matrix to Mimic Native Arterial Architecture Using Polycaprolactone, Elastin, and Collagen: A Preliminary Study.”Acta Biomaterialia, In Review. (Impact Factor: 3.727)

  3. Madurantakam, P.A.; Pacitti, A.P.; Bowlin, G.L. and M.J. Beckman. “Quantifying Biomaterial Cytocompatibility via In-Cell Assay of Phosphovinculin.” Biochemical and Biophysical Research Communications, In Review.

  4. Ayers, C.E.; Shekhar Jha, B.; Sell, S.A.; Bowlin, G.L. and D.G. Simpson. “Nanotechnology in the Design of Tissue Engineering Scaffolds: Innovations in Structure and Function.” Nanomedicine & Nanobiotechnology, In Press.

  5. Karrer, L.; Cikirikcioglu, M.; Khabiri, E.; Djebaili, M.K.; Pache, J.C.; Duwe, J.; Carrel, T.; Kalangos, A.; Bowlin, G.L. and B.H. Walpoth. “Assessment of Biocompatibility of Electrospun Biodegradable Scaffolds for Vascular Tissue Engineering.” International Journal of Artificial Organs, In Press.

  6. McClure, M.J., Sell, S.A.; Ayers, C.E.; Simpson, D.G. and G.L. Bowlin. “Electrospinning Aligned and Random Polydioxanone- and Polycaprolactone- Silk Fibroin Blended Scaffolds: Geometry for a Medial Matrix.” Biomedical Materials, 2009. (Times cited: 0; Impact Factor: 1.233)

  7. Madurantakam, P.; Rodriguez, I., Cost, C.; Moon, P.; Viswanathan, R.; Beckman, M.J.; Simpson, D.G. and. G.L. Bowlin. “A Study of Multiple Factor Interaction in Biomimetic Mineralization of Electrospun Bone Tissue Engineering Scaffolds.” Biomaterials, 30 (29), 5456-64, 2009. (Impact Factor: 6.646)

  8. Sell, S.A.; McClure, M.J.; Garg, K.; Wolfe, P.S. and G.L. Bowlin. “Electrospinning of Collagen / Biopolymers for Regenerative Medicine and Cardiovascular Tissue Engineering.” Advanced Drug Delivery Reviews (Invited review for special issue on nanofibers), 2009. (Impact Factor: 8.224)

  9. Smith, M.J.; Smith D.C.; White Jr., K.L. and G.L. Bowlin. “In Vitro Evaluations of Innate and Acquired Immune Response to Electrospun Polydioxanone and Collagen Blends.” Journal of Biomedical Materials Research-Part A, 2009. (Impact Factor: 2.612)

  10. Wolfe, P.S.; Madurantakam, P.; Garg, K.; Sell, S.A.; Beckman, M. and G.L. Bowlin. “Evaluation of Thrombogenic Potential of Electrospun Bioresorbable Vascular Graft Materials: Acute Monocyte Tissue Factor Expression.”  Journal of Biomedical Materials Research-Part A, 2009. (Times cited: 0; Impact Factor: 2.612)

  11. Garg, K.; Sell, S.A.; Madurantakam, P. and G.L. Bowlin. “Angiogenic Potential of Human Macrophages on Electrospun Bioresorbable Vascular Grafts.” Biomedical Materials, 2009. (Times cited: 0; Impact Factor: 1.233)

  12. McClure, M.J., Sell, S.A.; Walpoth, B.H.; and G.L. Bowlin. “Electrospun Polydioxanone, Elastin and Collagen Vascular Scaffolds: Uniaxial Cyclic Distension.” J. Engineered Fabrics and Fibers, 4(2), 18-25, 2009.

  13. Madurantakam, P.A.; Cost, C.P.; Simpson, D.G. and G.L. Bowlin. “Science of Nanofibrous Scaffold Fabrication: Strategies for Next Generation Tissue Engineering Scaffolds.” Nanomedicine, 4 (2), 193-206, 2009. (Times cited: 0; Impact Factor: 2.818)

  14. Newton, D.H.; Mahajan, R.; Ayres, C.E.; Bowman, J.R.; Bowlin, G.L. and D.G. Simpson. “Regulation of Material Properties in Electrospun Scaffolds:  Role of Cross-linking and Fiber Tertiary Structure.” Acta Biomaterialia, 5 (1), 518-29, 2009. (Times cited: 0; Impact Factor: 3.727)

  15. Smith, M.J.; Smith D.C.; White Jr., K.L. and G.L. Bowlin. “In Vitro Evaluations of Innate and Acquired Immune Responses to Electrospun Polydioxanone and Elastin Blends.” Biomaterials, 30 (2), 149-50, 2008. (Times cited: 0; Impact Factor: 6.262)

  16. Sell, S.A.; Francis, M.; Garg, K.; McClure, M.J.; Barnes, C.P.; Simpson, D.G. and G.L. Bowlin. “Cross-linking Methods of Electrospun Fibrinogen Scaffolds for Tissue Engineering.” Biomedical Materials, 3 (4), 1-11, 2008. (Times cited: 0; Impact Factor: 1.233)

  17. McManus, M.C.; Sell, S.A.; Bowen, W.C.; Koo, H.P. and G.L. Bowlin. “Electrospun Fibrinogen-Polydioxanone Composite Matrix: Potential for In Situ Urologic Tissue Engineering.” J. Engineered Fabrics and Fibers, 3 (2), 12-21, 2008.

  18. McClure, M.J.; Sell, S.A.; Barnes, C.P.; Bowen, W.C. and G.L. Bowlin. “Cross-linking Electrospun Polydioxanone-Soluble Elastin Blends: Material Characterization.” J. Engineered Fabrics and Fibers, 3 (1), 1-10, 2008.

  19. Manis, A.E.; Bowman, J.R.; Bowlin, G.L. and D.G. Simpson. “Electrospun Nitrocellulose and Nylon: Design and Fabrication of Novel High Performance Platforms Protein Blotting Applications.” J. Biological Engineering, 1 (2), 1-11, 2007. (New Journal – No Impact Factor)

  20. Ayres, C.E.; Shekhar Jha, B.; Meredith, H.; Bowman, J.R.; Bowlin, G.L.; Henderson, S.C. and D.G. Simpson. “Measuring Fiber Alignment in Electrospun Scaffolds: A User’s Guide to the 2D Fast Fourier Transform Approach.” J. Biomat. Sci. Poly. Ed., 19 (5), 603-21, 2008. (Times cited: 3; Impact Factor: 1.862)

  21. Sell, S.A.; Barnes, C.P.; Simpson, D.G. and G.L. Bowlin. “Scaffold Permeability as a Means to Determine Fiber Diameter and Pore Size of Electrospun Fibrinogen.”  J. Biomed. Mat. Res. Part A, 85, 115-126, 2008. (Times cited: 3; Impact Factor: 2.612)

  22. Carrizales, C.; Pelfrey, S.; Rincon, R.; Eubanks, T.; Kuang, A.; McClure, M.J.; Bowlin, G.L. and J.T. Macossay. “Thermal and Mechanical Properties of Electrospun PMMA, PVC, Nylon 6 and Nylon 6,6.” Polymers for Advanced Technologies, 19, 124-130, 2008. (Times cited: 0; Impact Factor: 1.504)

  23. Sell, S.A. and G.L. Bowlin. “The Potential to Create Small Diameter Bioresorbable Vascular Grafts Through Electrospinning.” Journal of Materials Chemistry, 18, 260-263, 2008 (Invited Highlight, mini-review). (Times cited: 1; Impact Factor: 4.339)

  24. Smith, M.J.; McClure, M.J.; Sell, S.A.; Barnes, C.P.; Walpoth, B.H.; Simpson, D.G. and G.L. Bowlin. “A Novel Suture-Reinforced Electrospun Polydioxanone-Elastin Small-Diameter Tube for Use in Vascular Tissue Engineering.” Acta Biomaterialia, 4, 58-66, 2008. (Times cited: 5; Impact Factor: 3.727)

  25. Barnes, C.P.; Sell, S.A.; Boland, E.D.; Simpson, D.G.; and G.L. Bowlin. “Nanofiber Technology: Designing the Next Generation of Tissue Engineering Scaffolds.”  Advanced Drug Delivery Reviews (Invited review for special issue on nanofibers), 59(14), 1413-1433, 2007. (Times cited: 31; Impact Factor: 8.224)

  26. Sell, S.A.; Barnes, C.P.; Simpson, D.G. and G.L. Bowlin. “Extracellular Matrix Regenerated: Tissue Engineering via Electrospun Biomimetic Nanofibers” Polymer International, 56, 13489-1360, 2007 (Invited Review). (Times cited: 11; Impact Factor: 1.557)

  27. McManus, M.C.; Boland, E.D.; Sell, S.A.; Bowen, W.C.; Koo, H.P.; Simpson, D.G. and G.L. Bowlin. “Electrospun Nanofibre Fibrinogen for Urinary Tract Tissue Reconstruction.” Biomedical Materials, 2, 257—262, 2007. (Times cited: 4; Impact Factor: 1.233)

  28. Smith, M.J.; Smith D.C.; White Jr., K.L. and G.L. Bowlin. “Immune Response Testing of Electrospun Polymers: An Important Consideration in the Evaluation of Biomaterials.” J. Engineered Fabrics and Fibers (Invited Editorial), 2(2), 41-47, 2007. (Times cited: 1; Impact Factor: In Process)

  29. Ayres, C.E.; Bowlin, G.L.; Henderson, S.C.; Taylor, L.; Telemeco, T.A. and D.G. Simpson. “Incremental Changes in Anisotropy: Modulation of Material Properties in Electrospun Tissue Engineering Scaffolds.” Acta Biomaterialia, 3, 651-661, 2007. (Times cited: 3; Impact Factor: 3.727)

  30. Ward, K.R.; Tibia, M.H.; Holbert, H.W.; Blocher, C.; Draucker, G.T.; Proffitt, E.K.; Bowlin, G.L.; R.R. Ivatury and R.F. Diegelmann. “Comparison of a New Hemostatic Agent to Current Combat Hemostatic Agents in a Swine Model of Lethal Extremity Arterial Hemorrhage.” J. Trauma, 63, 276-284, 2007. (Times cited: 7; Impact Factor: 2.334)

  31. Barnes, C.P.; Pemble, C.W.; Brand, D.D.; Simpson, D.G. and G.L. Bowlin. “Cross-linking Electrospun Type II Collagen Tissue Engineering Scaffolds with Carbodiimide in Ethanol.”  Tissue Engineering, 13(7), 1593-1605, 2007. (Times cited: 14; Impact Factor: 4.697)

  32. McManus, M.C.; Boland, E.D.; Simpson, D.G.; Barnes, C.P. and G.L. Bowlin. "Electrospun Fibrinogen: Feasibility as a Tissue Engineering Scaffold in a Rat Cell Culture Model.” J. Biomed. Mat. Res. Part A, 81A(2), 299-309, 2007. (Times cited: 18; Impact Factor: 2.612)

  33. Barnes, C.P.; Smith, M.J.; Bowlin, G.L.; Sell, S.A.; Tang, T.; Matthews, J.A.; Simpson, D.G. and J.C. Nimtz. “Feasibility of Electrospinning the Globular Proteins: Hemoglobin and Myoglobin.”  J. Engineered Fabrics and Fibers, 1 (2), 16-29, 2006 (Times cited: 7; Impact Factor: In Process)

  34.  Barnes, C.P.; Sell, S.A.; Knapp, D.C.; Walpoth, B.H.; Brand, D.D. and G.L. Bowlin. “Preliminary Investigation of Electrospun Collagen and Polydioxanone for Vascular Tissue Engineering Applications.”  International Journal of Electrospun Nanofibers and Applications, 1(1), 73-87, 2007. (New Journal – no impact factor)

  35. Ramdhanie, L.I.; Barnes, C.P.; Simpson, D.G.; Wnek, G.E. and G.L. Bowlin. “Thermal and Mechanical Properties of Electrospun Blends of Poly(lactic acid) and Poly(glycolic acid).” Polymer Journal, 38, 1137-1145, 2006. (Times cited: 3; Impact Factor: 1.412)

  36. Ayres, C.E.; Bowlin, G.L.; Henderson, S.C.; Taylor, L.; Schultz, J.; Alexander, J.K.; Telemeco, T.A. and D.G. Simpson. “Modulation of Anisotropy in Electrospun Tissue Engineering Scaffolds: Analysis of Fiber Alignment by the Fast Fourier Transform.” Biomaterials, 27, 5524-5534, 2006. (Times cited: 18; Impact Factor: 6.646)

  37.  Sell, S.A.; McClure, M.J.; Barnes, C.P.; Knapp, D.C.; Simpson, D.G.; Walpoth, B.H. and G.L. Bowlin. “Electrospun Polydioxanone – Elastin Blends: Potential for Bioresorbable Vascular Grafts.”  Biomedical Materials, 1, 72-80, 2006. (Times cited: 26; Impact Factor: 0.787)

  38. Simpson, D.G. and G.L. Bowlin.  “Tissue Engineering Scaffolds and Wound Repair Templates - Is It Possible to Engineer the 'Ideal' Structures?" Expert Review of Medical Devices, 3(1), 9-15, 2006 (Invited Editorial) (Times cited: 7; Impact Factor: 1.519).

  39. Walpoth, B.H. and G.L. Bowlin.  “The Daunting Quest for a Small Diameter Vascular Graft.” Expert Review of Medical Devices, 2 (6), 647-51, 2005 (Invited Editorial) (Times cited: 7; Impact Factor: 1.519).

  40. McManus, M.C.; Boland; E.D.; Koo, H.P.; Barnes, C.P.; Wnek, G.E.; Simpson, D.G. and G.L. Bowlin. “Mechanical Properties of Electrospun Fibrinogen Structures.” Acta Biomaterialia, 2, 19-28, 2006. (Times cited: 26; Impact Factor: 3.727)

  41. Telemeco,T.; Bowlin, G.L.; Wnek, G.E.; Boland, E.D.; Ayers, C.; Cohen, N.; Baumgarten, C.M.;  Matthews, J. and  D.G. Simpson. “Regulation of Cellular Infiltration into Tissue Engineering Scaffolds Composed of Submicron Diameter Fibrils Produced by Electrospinning.” Acta Biomaterialia, 1 (4), 377-385, 2005. (Times cited: 49; Impact Factor: 3.727)

  42. Boland, E.D., Coleman, B.D.; Barnes, C.P.; Simpson, D.G., Wnek, G.E. and G.L. Bowlin. "Electrospinning Polydioxanone for Biomedical Applications.” Acta Biomaterialia, 1 (1), 115-123, 2005. (Times cited: 38; Impact Factor: 3.113)

  43. Boland, E.D., Pawlowski, K.J., Simpson, D.G., Wnek, G.E. and G.L. Bowlin. “Biomedical Nanoscience: Electrospinning Basic Concepts, Applications and Classroom Demonstration.” J. of Materials Education, 26 (3-4), 195-206, 2004.

  44. Shields, K.J.; Beckman, M.J.; Bowlin, G.L. and J.S. Wayne. “Mechanical Properties and Cellular Proliferation of Electrospun Collagen Type II.” Tissue Engineering, 10 (9/10), 1510-1517, 2004. (Times cited: 56; Impact Factor: 4.697)

  45.  Boland, E.D., Telemeco,T.; Simpson, D.G., Wnek, G.E. and G.L. Bowlin. "Utilizing Acid Pretreatment and Electrospinning to Improve Biocompatibility of Poly(glycolic acid) for Tissue Engineering” J. Biomed. Mat. Res. B, Appl. Biomater., 71B, 144-152, 2004. (Times cited: 45; Impact Factor: 1.933)

  46. G.L. Bowlin.  "Scaffolds that Truly Mimic Nature.” Materials Today (Invited Opinion), 64, May 2004. (Times cited: 5)

  47. Pawlowski, K.J., Rittgers, S.E.; Schmidt, S.P. and G.L. Bowlin.  "Endothelial Cell Seeding of Polymeric Vascular Grafts.” Frontiers in Bioscience, 9, 1412-1421, May 1, 2004. (Invited Paper) (Times cited: 16; Impact Factor: 2.989)

  48. Boland, E.D., Matthews, J.A.; Pawlowski, K.J., Simpson, D.G., Wnek, G.E. and G.L. Bowlin.  "Electrospinning Collagens and Elastin for Vascular Tissue Engineering.” Frontiers in Bioscience, 9, 1422-1432, May 1, 2004. (Invited Paper) (Times cited: 107; Impact Factor: 2.989)

  49. Sanders, E.H.; Kloefkorn, R.; Bowlin, G.L.; Simpson, D.G.; and G.E. Wnek. “Two-Phase Electrospinning from a Single Electrified Jet: Microencapsulation of Aqueous Reservoirs in Poly(Ethylene-co-Vinyl Acetate) Fibers.” Macromolecules, 36, 3803-5, 2003. (Times cited: 61; Impact Factor: 4.411)

  50. Yao, L.; Haas, T.W.; Guiseppi-Elie, A.; Bowlin, G.L.; Simpson, D.G.; and G.E. Wnek. “Electrospinning and Stabilization of Fully Hydrolyzed Poly(vinyl alcohol) Fibers.” Chemistry of Materials, 15, 1860-64, 2003. (Times cited: 65; Impact Factor: 4.883)

  51. Wnek, G.E.; Carr, M.E.; Simpson, D.G.; and G.L. Bowlin. "Electrospinning of Nanofiber Fibrinogen Structures." Nano Letters, 3(2): 213-16, 2003. (Times cited: 170; Impact Factor: 9.627)

  52. Matthews, J.A.; Boland, E.D.; Wnek, G.E.; Simpson, D.G.; and G.L. Bowlin. "Electrospinning of Collagen Type II: A Feasibility Study." J. Bioactive and Compatible Polymers, 18, 125-34, 2003. (Times cited: 54; Impact Factor: 1.917)

  53. G.L. Bowlin.  "Electrospinning of Collagen: Finally the “Ideal” Tissue Engineering Scaffolds?” International Society of Applied Cardiovascular Biology Circulator – ISACB Essay, Fall/Winter 2002, 7-8, 2002.

  54. G.L. Bowlin.  "Electrospinning Collagen Scaffolds.” Science and Medicine, 8: 292-93, November/December 2002. (Times cited: 2)

  55. Kenawy, E.; Layman, J.; Matthews, J.A.; Bowlin, G.L.; Simpson, D.G.; and G.E. Wnek. "Electrospinning of Poly(Ethylene-co-Vinyl Alcohol) Fibers." Biomaterials, 24: 907-13, 2003. (Times cited: 89; Impact Factor: 6.262)

  56. Fields, C.; Cassano, A.; Allen, C.; Meyer, A.; Rittgers, S.E.; Szycher, M.; Pawlowski, K.J.; and G.L. Bowlin.  "Endothelial Cell Seeding of a 4-mm I.D. Polyurethane Vascular Graft.” J. Biomaterials Applications, 17(1): 45-70, 2002. (Times cited: 10; Impact Factor: 1.651)

  57. Boland, E.D.; Wnek, G.E.; Simpson, D.G.; Pawlowski, K.J. and G.L. Bowlin. "Tailoring Tissue Engineering Scaffolds Using Electrostatic Processing Techniques: A Study of Poly(Glycolic Acid)." J. Macromol. Sci – Pure Appl. Chem., 38: 1231-43, 2001. (Times cited: 150; Impact Factor: 0.759)

  58. Matthews, J.A.; Simpson, D.G.; Wnek, G.E.; and G.L. Bowlin. "Electrospinning of Collagen Nanofibers." Biomacromolecules, 3 (2): 232-238, 2002. (Times cited: 500; Impact Factor: 4.169)

  59. Kenawy, E.; Bowlin, G.L.; Mansfield, K.; Layman, J.; Simpson, D.G.; Sanders, E.H. and G.E. Wnek. "Release of Tetracycline Hydrochloride from Electrospun Poly(ethylene-co-vinylacetate), Poly(lactic acid), and a Blend." J. Control Release, 81 (1,2): 57-64, 2002. (Times cited: 246; Impact Factor: 4.756)

  60. Fields, C.; Cassano, A.; Allen, C.; Sims, R.; Bulgrin, J.; Meyer, A.; Makhoul, R.G.; Rittgers, S.E.; and G.L. Bowlin.  "Evaluation of Electrostatically Endothelial Cell Seeded Expanded Polytetrafluoroethylene Grafts in a Canine Femoral Artery Model." J. Biomaterials Applications, 17 (2): 135-154, 2002. (Times cited: 9; Impact Factor: 1.651)

  61. Fields, C.; Cassano, A.; Allen, C.; Meyer, A.; Rittgers, S.E.; Makhoul, R.G. and G.L. Bowlin. "The Persistence of Electrostatically Seeded Endothelial Cells Lining a Small Diameter Expanded Polytetrafluoroethylene Vascular Graft." J. Biomaterials Applications, 16: 157-73, 2001. (Times cited: 10; Impact Factor: 1.651)

  62. Stitzel, J.D.; Pawlowski, K.J.; Wnek, G.E.; Simpson, D.G.; Bowlin, G.L.. "Arterial Smooth Muscle Cell Proliferation on a Novel Biomimicking, Biodegradable Vascular Graft Scaffold." J. Biomaterials Applications, 16: 22-33, 2001. (Times cited: 32; Impact Factor: 1.651)

  63. Bowlin, G.L.; Rittgers, S.E.; Schmidt, S.P.; Alexander, T.; Sheffer, D.B.; and Milsted, A. "Optimization of an Electrostatic Endothelial Cell Transplantation Technique Using 4 mm I.D. e-PTFE Vascular Prostheses." Cell Transplantation, 9: 337-48, 2000. (Times cited: 6; Impact Factor: 3.871)

  64. Bowlin, G.L.; Rittgers, S.E.; Milsted, A.; and Schmidt, S.P. "In Vitro Evaluation of Electrostatic Endothelial Cell Transplantation onto 4 mm I.D. e-PTFE Grafts." J. Vasc. Surg., 27: 504-11, 1998. (Times cited: 18; Impact Factor: 3.272)

  65. Bowlin, G.L. and S.E. Rittgers. “Electrostatic Endothelial Cell Seeding of Small Diameter (< 6 mm) Vascular Prostheses: Feasibility Study.” Cell Transplantation 6: 623-9, 1997. (Times cited: 25; Impact Factor: 3.871)

  66. Bowlin, G.L. and S.E. Rittgers. “A Prototype Apparatus and Procedure for Electrostatic Endothelial Cell Transplantation within Small Diameter (< 6 mm) Vascular Prostheses.” Cell Transplantation 6: 631-7, 1997. (Times cited: 17; Impact Factor: 3.871)

Patents

  1. U.S. Patent # 7,374,774: “Electroprocessed Material Made by Simultaneously Electroprocessing a Natural Protein Polymer and Two Synthetic Polymers.” Bowlin, G.L., Wnek, G.E., and D.G. Simpson.Virginia Commonwealth University. Issued: May 20, 2008

  2. European Patent # EP1853326: “Mineral Technologies for Acute Hemostasis and for the Treatment of Acute and Chronic Ulcers.’Diegelmann, R.F., Ward, K.R., Carr Jr., M.E. and G.L. Bowlin. Virginia Commonwealth University. Issued: November 14, 2007

  3. European Patent # EP1555957: “Sealants for Skin and other Tissues.” Bowlin, G.L., Simpson, D.G., Wnek, G.E., Stevens, P.J., Cadd, G., Cohen, I.K. and M.E. Carr. Virginia Commonwealth University and NanoMatrix, Inc. Issued: July 27, 2005

  4. European Patent # EP1212107: “Engineered Muscle.” Bowlin, G.L., Wnek, G.E., Simpson, D.G. and L. Terracio.Virginia Commonwealth University. Issued August 8, 2005

  5. U.S. Patent # 6,787,357: “Plasma-derived Fibrin-based Matrices and Tissue.” Bowlin, G.L., Wnek, G.E., Simpson, D.G., Lam, P., Carr, M.E., and H. Fillmore. Virginia Commonwealth University. Issued: September 7, 2004

  6. European Patent # EP1315756: “Electroprocessed Fibrin-based Matrices and Tissues.”
    Bowlin, G.L., Wnek, G.E., Simpson, D.G., Lam, P. and M.E. Carr. Virginia Commonwealth University. Issued: June 4, 2003

  7. U.S. Patent # 6,592,623: “Engineered Muscle.” Bowlin, G.L., Wnek, G.E., Simpson, D.G. and L. Terracio. Virginia Commonwealth University. Issued: July 15, 2003

  8. European Patent # EP1318778: “Treatment for High Pressure Bleeding.” Wnek, G.E., Carr, M.E., Cohen, I.K., Bowlin, G.L., Ward, K.R., Barbee, W. and R. Ivatury. Virginia Commonwealth University. Issued: June 18, 2003

  9. European Patent # EP1315756: “Electroprocessed Composition Used in Drug Delivery and Cell Encapsulation.” Simpson, D.G., Bowlin, G.L. and G.E. Wnek. Virginia Commonwealth University. Issued: August 13, 2003

  10. European Patent # EP1345743: “Electroprocessed Collagen.” Simpson, D.G., Bowlin, G.L., Wnek, G.E., Stevens, P.J., Carr, M.E., Matthews, J. and S. Rajendran. Virginia Commonwealth University. Issued: September 24, 2003

  11. European Patent # EP1092009:  “Apparatus and Method for Electrostatic Endothelial Cell Seeding and DNA Transfection of Intravascular Stents.” Bowlin, G.L., Virginia Commonwealth University. Issued: April 18, 2001

  12. U.S. Patent # 6,010,573: “Apparatus and Method for Electrostatic Endothelial Cell Seeding and DNA Transfection of Intravascular Stents.” Bowlin, G.L., Virginia Commonwealth University. Issued: January 4, 2000

  13. U.S. Patent # 5,714,359: "Electrostatic Endothelial Cell Seeding: Apparatus and Procedure." Bowlin, G.L. and S.E. Rittgers, The University of Akron. Issued: February 3, 1998

  14. U.S. Patent # 5,723,324: “Apparatus and Method for Electrostatic Endothelial Cell Seeding and DNA Transfection in a Vascular Prosthesis.” Bowlin, G.L. and S.E. Rittgers, The University of Akron. Issued: March 3, 1998

  15. Mexican Patent # 232271: “Engineered Muscle.” Bowlin, G.L., Wnek, G.E., Simpson, D.G. and L. Terracio. Virginia Commonwealth University